Učitavanje...
What 20 years of research has taught us about the TP53 p.R337H mutation
The p53 tumor suppressor transcriptionally regulates a myriad of genes involved in cell cycle control, DNA repair, cell survival, and cell metabolism and represents one of the most well‐studied inhibitors of tumorigenesis. Since the discovery of TP53 in 1979, somatic mutations have been shown to be...
Spremljeno u:
| Izdano u: | Cancer |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7589304/ https://ncbi.nlm.nih.gov/pubmed/32875577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.33143 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|